suMMARY Ten patients who suffered spontaneous paroxysms of atrial flutter were investigated by electrophysiological techniques. Two had overt Wolff-Parkinson-White syndrome; three LownGanong-Levine syndrome; and one a concealed accessory atrioventricular connection. Atrial flutter was initiated, at study, by right atrial pacing and electrograms from the right atrium and coronary sinus were observed for at least five minutes to ensure stable flutter in both atria.
In 1967, Haft and coworkers' reported the successful termination of atrial flutter by rapid atrial pacing. They also suggested that premedication with quinidine-like drugs potentiated the success of the technique. Though others2-"1 have used atrial pacing techniques to treat atrial flutter with variable and, at times, contradictory results'2 13 little attention has been given to pretreatment with antiarrhythmic agents. Here we report the individual and combined results of overdrive atrial pacing and intravenous disopyramide phosphate in the treatment of paroxysms of atrial flutter.
Subjects and methods
Ten patients aged between 22 and 62 years were investigated for complaints of recurrent paroxysmal palpitations (Table 1 ). All patients had suffered documented attacks of atrial flutter and three patients also had attacks of "supraventricular"
Received for publication 18 February 1980 tachycardia which were not thought to be atrial flutter. One patient presented with profound sinus bradycardia, sinus node arrest, and paroxysms of tachycardia. There was no clinical or radiographic evidence of organic heart disease though two patients were mildly hypertensive. The surface electrocardiogram was normal in four patients, showed sinus bradycardia in one, and a short PR interval in five. In two patients, the short PR interval was followed by broad QRS complexes of the Wolff-Parkinson-White pattern, type A. Routine blood tests, including thyroid function tests, were normal in all patients.
The patients underwent intracardiac electrophysiological investigation in 
Results
The results of routine electrophysiological studies in the 10 patients are summarised in Table 1 . In six patients, no electrophysiological abnormality could be detected, but in one, abnormal sinus node function was documented and, in three, left-sided accessory atrioventricular pathways were disclosed and re-entrant tachycardias, using these pathways in the retrograde direction, were precipitated. In all 10 patients, stable atrial flutter of both chambers was initiated by atrial pacing. The initial flutter frequency, the ventricular response rate, and the atrioventricular ratio are set out in Table 2 , and illustrated in Fig. 1 and 2 . The flutter rate varied between 230 beats/min and 375 beats/min (mean= 310 ±39 beats/min), and in eight cases characteristic "saw tooth" flutter waves were seen, but, in two, both with overt Wolff-ParkinsonWhite syndrome, baseline oscillations were obscured The infusion of disopyramide phosphate resulted in reduction of the atrial rate in all patients. The mean atrial rate fell significantly (p <0-001) from 310 ±39 beats/min to 217 ±27 beats/min (Fig. la) . In one patient atrial flutter terminated six minutes after the start of the disopyramide infusion. The ventricular rate response to disopyramide infusion was variable. Fig. 4 illustrates the response in case 9. Initially, the atrioventricular rate was 280 beats/min, and five minutes after the conclusion of the disopyramide infusion the 1 :1 atrioventricular relation persisted at a rate of 194 beats/min. In case 7 ( In six patients, the ventricular rate increased at some time during the 10 minute observation period (Fig. ic) and the mean increase (161 ±52 to 189 ±49 beats/min) was significant (p <0-01). By the end of the observation period (Fig. lb) there was an insignificant fall in the mean ventricular rate (161 ±57 to 156 ±45 beats/min), but the atrioventricular conduction ratio had significantly (p < 0 01) fallen (2-17 ±0-86 to 1*55 A±0 59).
In nine patients, the termination of the arrhythmia by overdrive atrial pacing was attempted again after the infusion of disopyramide. The technique proved successful in seven cases, six of whom had not responded before disopyramide. In the two failures it was not possible to achieve atrial capture. In the successful cases, atrial pacing usually resulted in transient runs of atrial tachycardia or fibrillation before conversion to sinus rhythm. Atrial fibrillation of a duration longer than 5 s was not precipitated except in the two failures, who after completing the study were subjected to longer and faster periods of atrial pacing. One of these patients eventually required direct current cardioversion. The overall results of the combined technique are illustrated in Fig. 7 . The effect of disopyramide on atrial flutter has not been reported in detail. Though Luoma et al. 33 studied patients with atrial flutter, they did not distinguish this arrhythmia from atrial fibrillation. In the cases reported by Vandenbosch et al.,34 disopyramide converted three of 11 examples of atrial flutter and, in the series of Deano et al.,35 three of eight patients reverted to sinus rhythm in response to disopyramide. Our rate of success with conversion was comparatively low and while this may be partly related to the short observation period, previous experience with intravenous disopyramide indicated that the majority of terminations occurred within 10 minutes of the start of the infusion36 and, in any event, it is difficult to ascribe late terminations to the action of the drug. 37 In this series, as in others,34 35 disopyramide resulted in consistent and pronounced slowing of the atrial flutter frequency. In the presence of 1:1 atrioventricular conduction, the ventricular rate also slowed, but when a degree of atrioventricular conduction block was present, the infusion 
